SMAD2 and Myocardial fibrosis: Thus, our findings suggest that the activation of TRPM7/Smad2 signaling by Ang II is an important mechanism leading to myocardial fibrosis in SAN tissues in SSS rats, indicating that TRPM7 is a potentially therapeutic target for SSS treatment.